Epoch Biodesign Is Turning Plastic Waste Into New Fabric — And Lululemon Just Bet Big on It
A biotech startup founded by a former high school science obsessive has found a way to use enzymes to dissolve synthetic fabric waste back into raw material — and one of the world's most recognizable athletic wear brands just placed a major bet on the technology. Here is everything you need to know about why Epoch Biodesign could change the future of what you wear.
 |
| Credit: Epoch Biodesign |
The Problem With Your Activewear That Nobody Talks About
Every pair of stretchy leggings, moisture-wicking base layer, or performance shorts ever made has a dirty secret. Most athletic clothing is made from synthetic fabrics — materials that are, at their core, plastic. And when those items wear out, there is almost nowhere for them to go except into the ground, where they will sit for hundreds of years without breaking down.
The oil and gas industry has long understood this. As the global economy shifts toward electric vehicles and cleaner energy, petroleum-dependent companies have quietly recalibrated their long-term strategies around plastics. More plastic in clothing, packaging, and consumer goods means continued demand for fossil fuel derivatives, regardless of what happens to the car industry. It is a lifeline disguised as a lifestyle product.
This is the system that Jacob Nathan, founder and CEO of Epoch Biodesign, has dedicated his career to disrupting.
From High School Lab Curiosity to Biotech Breakthrough
Nathan did not wait until university to start asking hard questions about plastic waste. He began searching for biological solutions to synthetic material pollution while still in high school — a preoccupation that eventually led him to found Epoch Biodesign.
The company's core technology relies on a carefully engineered series of enzymes. These biological molecules are designed to break down synthetic fabrics — materials the natural world was never built to handle — into their component parts. Nathan describes the process as transforming what he calls "unnatural waste" into a form that is ready to become new plastic again.
That last part is worth sitting with. Epoch Biodesign is not just disposing of old fabric. It is creating a circular supply loop, where the material from worn-out garments feeds directly back into the production of new ones. This is not recycling in the traditional sense of melting something down and hoping the quality holds. This is molecular-level recovery.
Why Lululemon Is Paying Attention
Lululemon has built its identity around premium athletic apparel — tight tolerances, premium feel, and a consumer base that expects their gear to last. But lasting gear still eventually ends up in the bin, and the brand has faced growing scrutiny over what happens to its products at the end of their life.
By backing Epoch Biodesign, Lululemon is making a specific kind of statement. It is not just funding a recycling initiative or planting trees. It is investing in technology that could, in theory, close the loop on its own products — where old Lululemon shorts get broken down and the resulting material is used to make new Lululemon shorts.
The move signals a broader shift in how performance apparel brands are beginning to think about material sustainability. Rather than treating end-of-life fabric as a disposal problem, brands like Lululemon are beginning to treat it as a resource problem. And resource problems have solutions.
What Enzyme-Based Fabric Recycling Actually Means
To understand why this technology matters, it helps to understand why conventional recycling struggles with synthetic fabrics in the first place.
Most synthetic textiles are made from polymers — long molecular chains that are strong, flexible, and highly resistant to breaking down. That durability is exactly what makes them useful in activewear, and exactly what makes them nightmarish to recycle. Traditional mechanical recycling grinds materials down, which degrades the polymer chains and produces lower-quality output. Chemical recycling uses harsh solvents, which raise their own environmental concerns.
Enzymes offer a different path. These are naturally occurring biological catalysts that can be engineered to target specific molecular bonds. Epoch Biodesign has developed a suite of enzymes tuned to attack the precise bonds that hold synthetic fabrics together, breaking polymer chains back down to their monomer building blocks. Those monomers are essentially virgin-quality raw material, suitable for producing new fabric without quality loss.
This means the recovered material is not a downgraded byproduct. It is functionally equivalent to freshly manufactured input — which dramatically changes the economics of recycling for high-performance textiles.
Synthetic Fabric Waste Is a Massive Unresolved Crisis
The scale of the problem Epoch Biodesign is addressing is difficult to overstate. The global fashion industry produces enormous quantities of textile waste annually, and the majority of that waste involves some form of synthetic material. Of all the fabric collected for recycling, only a fraction is genuinely recycled into new textile-grade fiber. The rest is downcycled into insulation or industrial rags, or it simply ends up in landfill.
Activewear is a particular offender. The stretch, performance, and moisture-management properties that consumers demand from athletic clothing almost always require synthetic polymers — typically nylon, polyester, elastane, or some combination of the three. These materials are difficult to separate, difficult to recycle mechanically, and essentially impossible to break down through conventional biological processes.
Epoch Biodesign's enzyme approach targets this exact gap. By engineering biology to do what chemistry and mechanics cannot do efficiently, the company is opening up a class of material that has largely been written off by the recycling industry.
What This Means for the Future of Fashion Sustainability
The relationship between Lululemon and Epoch Biodesign is early stage, but it points toward a model that other major apparel brands are likely watching closely. If enzyme-based recycling can be scaled and made economically viable, it represents something the fashion industry has been promising for years without delivering: a genuine, technically credible pathway to circular materials.
For consumers, this could eventually mean something tangible. The old leggings you drop off at a takeback bin might actually become new fabric, not insulation padding. The brand promise of sustainability would be backed by a real molecular chain of custody rather than a feel-good marketing narrative.
It also shifts the competitive landscape in an interesting direction. Brands that secure early access to recycling technologies — or that invest in the companies developing them — could find themselves with a structural advantage as regulatory pressure on textile waste increases globally. Governments across Europe and increasingly in other regions are moving toward extended producer responsibility frameworks, which hold brands financially accountable for the end-of-life treatment of their products.
Owning or having preferential access to a credible recycling solution starts to look less like corporate social responsibility and more like a strategic hedge.
Jacob Nathan and the Science of Stubborn Optimism
There is something worth noting about the kind of founder Jacob Nathan represents. He did not stumble into this problem after a career in adjacent fields. He identified it as a teenager, stayed with it through the long, difficult work of building a company, and emerged with technology that major global brands are now willing to put money behind.
Epoch Biodesign is, in a real sense, the product of a person who refused to accept that synthetic fabric waste was an unsolvable problem. In a startup landscape often criticized for chasing marginal improvements to already-comfortable industries, a company trying to biologically dissolve the plastic in discarded athletic shorts stands out.
Whether or not Epoch Biodesign delivers on its potential at scale remains to be seen. The distance between a functioning enzyme system in a lab and a commercially viable industrial recycling operation is enormous, and many promising material technologies have struggled to make that crossing. But the science is compelling, the problem is real, and now there is serious capital and a brand partner with a direct commercial incentive to help make it work.
Sometimes that combination is enough.
